Biosimilars and access to biologic therapy in immune-mediated diseases
{{output}}
Background: The rise of biologic agents has been a major breakthrough in treating immune-mediated inflammatory diseases (IMIDs). However, their high cost underscores the need for strategies to optimize treatment efficiency. Biosi... ...
